Research progress on sarcopenia in patients with lung cancer
10.16151/j.1007-810x.2024.03.010
- VernacularTitle:肺癌病人合并肌少症研究进展
- Author:
Dan-Ni DONG
1
;
Qiao CHU
;
Mi XIANG
;
Ya-Ping HE
Author Information
1. 上海交通大学医学院公共卫生学院,上海 200025
- Keywords:
Lung cancer;
Sarcopenia;
Clinical outcomes;
Physical activity;
Quality of life
- From:
Parenteral & Enteral Nutrition
2024;31(3):184-188,192
- CountryChina
- Language:Chinese
-
Abstract:
Sarcopenia is a syndrome associated with decreased muscle mass,decreased muscle strength,and reduced physical performance. Due to multiple factors such as tumor metabolism,systemic inflammatory response,disease progression,and reduced physical activity associated with treatment itself,the risk of sarcopenia in patients with lung cancer is higher than that of the general population. Sarcopenia is closely related to the clinical outcomes,including increased risk for mortality,and significantly impacts patients' long-term quality of life and mental health. This study systematic reviewed the risk factors for sarcopenia in patients with lung cancer,its negative effects on clinical outcomes,long-term quality of life and mental health,and the interventions for sarcopenia. Given the significant impact of sarcopenia on patients with lung cancer,it is urgent to explore a multidisciplinary intervention model to improve their survival and quality of life.
